ROTE WILLIAM E. bought TVTX
December 24, 2025 · Form 4 insider transaction
ROTE WILLIAM E. bought 60,000 shares of Travere Therapeutics, Inc. at $20.61 per share, a transaction worth $1.24M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$20.61
Total value
$1.24M
InsiderROTE WILLIAM E.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 24, 2025
Filing dateDecember 29, 2025
Shares owned after161,443
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 607 shares of Common Stock that were acquired by the Reporting Person on May 30, 2025, and 595 shares of Common Stock that were acquired by the Reporting Person on November 28, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.